Related Experiment Video
Updated: Jun 10, 2025
Tissue Characterization after a New Disaggregation Method for Skin Micro-Grafts Generation
Published on: March 4, 2016
Comparative Analysis of Autologous Skin Cell Suspension Technology and Split-Thickness Skin Grafting for Subacute
Lisa J Gould1, Cheryl Acampora1, Mimi Borrelli2
1From the Department of Surgery, South Shore Hospital, South Weymouth, MA (Gould, Acampora).
Background:
Nonhealing wounds are particularly prevalent in older adults and in patients with multiple comorbidities, and they represent a significant medicoeconomic burden. Autologous split-thickness skin grafts (STSGs) are considered the gold standard for wound closure but suffer from high failure rates and complications. Autologous skin cell suspension (ASCS) technology is an autografting technique able to significantly minimize donor site morbidity. This retrospective, propensity-matched cohort study compared outcomes of wounds treated with ASCS vs STSG.
Study Design:
Seven patients treated with ASCS were propensity-matched to 7 control patients who received STSG according to age and sex. The ASCS was prepared using the RECELL System and applied either alone as spray only ("ASCS alone," off-label) or combined with a widely meshed STSG ("ASCS + STSG," 3:1). The primary outcome was time to complete wound healing. Secondary outcomes included donor site healing, pain, and total number of visits. Statistical analyses included descriptive statistics, univariate analyses, and mixed-effect regression modeling to assess the impact of treatment on wound healing.
Results:
A total of 14 patients and 17 wounds (10 treatment vs 7 control) were included. Demographics were well-matched between cohorts. The overall mean wound healing time was 85.6 ± 11.2 days. Wounds treated with ASCS (both ASCS groups) healed faster than STSG (75.9 ± 4.5 vs 99.4 ± 26.7 days). Wounds treated with ASCS alone healed in 80.8 ± 5.1 days, whereas those treated with ASCS and STSG healed in 68.5 ± 7.6 days.
Conclusions:
This study suggests that ASCS may offer clinically significant improvements in wound and donor site healing, with significantly less donor skin requirements, and comparable pain levels, compared with traditional STSG. Further research with a prospective study and larger sample size is needed to validate these findings.
